[PPARgamma agonists--antidiabetics with positive effects on cardiovascular risk?].
Peroxisome proliferator-activated receptor agonists are used as an antidiabetic drug with particular effect on insulin sensitivity. This paper is based upon own literature and a Medline search. The drug improves insulin sensitivity, but has several cardiovascular effects as well. Blood pressure, serum lipids, endothelial function, inflammation and growth of smooth muscle are all modulated by these agonists. This group of drugs shows constant antiatherosclerotic properties. Larger clinical studies will give the answer whether this treatment can reduce micro- and macro-vascular complications in diabetes.